Drugmakers, insurers, hospitals, pharmacies, medical devices, clinical updates, and healthcare business leaders.
Eli Lilly and Company, trading on the NYSE as LLY, was included in a list of dividend stocks aimed at long-term investors after Reuters reported the company is preparing a new weight-loss launch.
THE APEX TIMES
THE APEX TIMES
Nike is bringing in new financial leadership as it continues a “Win Now” turnaround effort, according to a report that cites a $7.3 million “new hire” cash award tied to the CFO role.
THE APEX TIMES
The biotech behind an experimental hair-loss treatment said a clinical trial showed the program was well-tolerated and remained in the body for a long time, helping support renewed momentum after a $100 million financing backed by Eli Lilly.
THE APEX TIMES
The board of directors approved a per-share cash dividend payable Sept. 1, 2026, for Pfizer common stockholders.
THE APEX TIMES
A market commentary piece on Yahoo Finance lists UnitedHealth Group (UNH) among the long-term selections attributed to Appaloosa Management founder David Tepper, but provides limited details on the size or timing of the stake.
THE APEX TIMES
The company reiterated its 2026 financial outlook in the context of a reported leadership change, while attention remains on its shareholder payouts.
THE APEX TIMES
A market-focused report says Pfizer was removed from a lawsuit brought by U.S. states over alleged generic-drug price fixing. Pfizer’s response was described in later remarks, but key legal details were not specified in the post.
THE APEX TIMES
Pfizer said the U.S. Food and Drug Administration has approved an IBRANCE-based regimen as a maintenance option for people with hormone receptor-positive, HER2-positive metastatic breast cancer, paired with trastuzumab and optionally pertuzumab.
THE APEX TIMES
In an interview on NYSE Live, Abridge’s chief executive described fresh collaboration efforts with Nvidia and Eli Lilly, without laying out terms or technical specifics. The comments underscore the growing push to bring AI copilots into clinical workflows and life-sciences settings.
